Phytochemical linarin enriched in the flower of Chrysanthemum indicum inhibits proliferation of A549 human alveolar basal epithelial cells through suppression of the akt-dependent signaling pathway

Journal of Medicinal Food

Volumn 16, Issue 12, 2013, Pages 1086-1094

  Seo, Dong Wan ^a   Cho, Young Rak ^a   Kim, Wooki ^b   Eom, Seok Hyun ^b  

^a Dankook University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Chrysanthemum indicum; Heat dry process; Linarin; Lung cancer

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHRYSANTHEMUM INDICUM EXTRACT; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LINARIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHRYSANTHEMUM INDICUM; CONTROLLED STUDY; EPITHELIUM BASAL CELL; FLOWER; HEAT TREATMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMONES; CHRYSANTHEMUM; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPITHELIAL CELLS; FLOWERS; GLYCOSIDES; HUMANS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PHYTOCHEMICALS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 84890538256     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2674     Document Type: Article

References (36)

1. Cheng W, Li J, You T, Hu C: Anti-inflammatory and immunomodulatory activities of the extracts from the inflorescence of Chrysanthemum indicum Linne. J Ethnopharmacol 2005;101: 334-337.
2. Lee DY, Choi G, Yoon T, Cheon MS, Choo BK, Kim HK: Antiinflammatory activity of Chrysanthemum indicum extract in acute and chronic cutaneous inflammation. J Ethnopharmacol 2009;123: 149-154.
3. Shunying Z, Yang Y, Huaidong Y, Yue Y, Guolin Z: Chemical composition and antimicrobial activity of the essential oils of Chrysanthemum indicum. J Ethnopharmacol 2005;96: 151-158.
4. Ukiya M, Akihisa T, Tokuda H, et al.: Constituents of Compositae plants: III. Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers. Cancer Lett 2002; 177: 7-12.
5. Li ZF, Wang ZD, Ji YY, et al.: Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract. World J Gastroenterol 2009;15: 4538-4546.
6. Wang ZD, Huang C, Li ZF, et al.: Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target. Oncol Rep 2010;23: 413-421.
7. Lee SC, Jeong SM, Kim SY, Nam KC, Ahn DU: Effect of farinfrared irradiation on the antioxidant activity of defatted sesame meal extracts. J Agric Food Chem 2005;53: 1495-1498.
8. Kim SY, Jeong SM, Jo SC, Lee SC: Application of far-infrared irradiation in the manufacturing process of green tea. J Agric Food Chem 2006;54: 9943-9947.
9. Eom SH, Jin CW, Park HJ, et al.: Far infrared ray irradiation stimulates antioxidant activity in Vitis flexuosa Thumb. berris. Korean J Med Crop Sci 2007;15: 319-323.
10. Eom SH, Park HJ, Seo DW, Kim WW, Cho DH: Stimulating effects of far-infrared ray radiation on the release of antioxidative phenolics in grape berries. Food Sci Biotechnol 2009;18: 362-366.
11. Rho HS, Ahn SM, Lee BC, et al.: Changes in flavonoid content and tyrosinase inhibitory activity in kenaf leaf extract after farinfrared treatment. Bioorg Med Chem Lett 2010;20: 7534-7536.
12. Hamanaka D, Uchino T, Furuse N, Han W, Tanaka S: Effect of the wavelength of infrared heaters on the inactivation of bacterial spores at various water activities. Int J Food Microbiol 2006;108: 281-285.
13. Kim YJ, Hwang B, Ahn JC: Bioceramic effects to enhance secondary metabolites production in tissue culture of some medicinal plants. Korean J Med Crop Sci 2004;12: 118-122.
14. Toyokawa H, Matsui Y, Uhara J, et al.: Promotive effects of farinfrared ray on full-thickness skin wound healing in rats. Exp Biol Med (Maywood) 2003;228: 724-729.
15. Cho YR, Kim SH, Ko HY, Kim MD, Choi SW, Seo DW: Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of p70(S6K)-dependent VEGFR-2 expression. Oncol Rep 2011;26: 861-867.
16. Kim SH, Cho YR, Kim MD, Kim HJ, Choi SW, Seo DW: Inhibitory effects of sepiapterin on vascular endothelial growth factor-a-induced proliferation and adhesion in human umbilical vein endothelial cells. Arch Pharm Res 2011;34: 1571-1577.
17. Seo DW, Saxinger WC, Guedez L, Cantelmo AR, Albini A, Stetler-Stevenson WG: An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and antitumorigenic activity in vivo. Peptides 2011;32: 1840-1848.
18. Cho YR, Choi SW, Seo DW: Sepiapterin regulates cell proliferation and migration: its association with integrin alpha 3 beta 1 and p53 in human lung cancer cells. Genes Genom 2011;33: 577-582.
19. Seo DW, Li HM, Qu CK, et al.: Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem 2006;281: 3711-3721.
20. Seo DW, Kim SH, Eom SH, et al.: TIMP-2 disrupts FGF-2- induced downstream signaling pathways. Microvasc Res 2008;76: 145-151.
21. Kim SH, Cho Y-R, Kim H-J, et al.: Antagonism of VEGF-A- induced increase in vascular permeability by an integrin a3b1- Shp-1-cAMP/PKA pathway. Blood 2012;120: 4892-4902.
22. Eom SH, Park HJ, Jin CW, et al.: Changes in antioxidant activity with temperature and time in Chrysanthemum indicum L. Teas during elution processes in hot water. Food Sci Biotechnol 2008;17: 408-412.
23. Nicholson KM, And erson NG: The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002;14: 381-395.
24. Lemmon MA, Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 2010;141: 1117-1134.
25. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011;144: 646-674.
26. Malumbres M, Barbacid M: Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009;9: 153-166.
27. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13: 1501-1512.
28. Fujita N, Sato S, Katayama K, Tsuruo T: Akt-dependent phosphorylation of p27Kip1Promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem 2002;277: 28706-28713.
29. Viglietto G, Motti ML, Bruni P, et al.: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002;8: 1136-1144.
30. Xia W, Chen J-S, Zhou X, et al.: Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin Cancer Res 2004;10: 3815-3824.
31. Mactavish HS, Menary RC: The effect of flower maturity and harvest timing on floral extract from Boronia megastigma (Nees). Ann Bot 1997;80: 299-303.
32. Li YH, Wen SP, Kota BP, et al.: Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J Ethnopharmacol 2005;99: 239-244.
33. Duh PD, Tu YY, Yen GC: Antioxidant activity of water extract of harng jyur (Chrysanthemum morifolium Ramat). LWT-Food Sci Technol 1999;32: 269-277.
34. Kim KT, Yoo KM, Lee JW, Eom SH, Hwang IK, Lee CY: Protective effect of steamed American ginseng (Panax quinquefolius L.) on V79-4 cells induced by oxidative stress. J Ethnopharmacol 2007;111: 443-450.
35. Lee SC, Kim JH, Jeong SM, Ha JU, Nam KC, Ahn DU: Antioxidant activity of organic solvent extracts from far infraredtreated rice hulls. Food Sci Biotechnol 2004;13: 172-175.
36. Singh RP, Agrawal P, Yim D, Agarwal C, Agarwal R: Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate. Carcinogenesis 2005;26: 845-854.